64
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Ubiquitin-Specific Protease USP6 Regulates the Stability of the c-Jun Protein

, , , , , , , , , , , , , , , , , & show all
Article: e00320-17 | Received 14 Jun 2017, Accepted 12 Oct 2017, Published online: 03 Mar 2023

REFERENCES

  • Angel P, Karin M. 1991. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072:129–157.
  • Shaulian E, Karin M. 2002. AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131–E136. https://doi.org/10.1038/ncb0502-e131.
  • Vogt PK. 2002. Fortuitous convergences: the beginnings of JUN. Nat Rev Cancer 2:465–469. https://doi.org/10.1038/nrc818.
  • Mechta-Grigoriou F, Gerald D, Yaniv M. 2001. The mammalian Jun proteins: redundancy and specificity. Oncogene 20:2378–2389. https://doi.org/10.1038/sj.onc.1204381.
  • Johnson RS, van Lingen B, Papaioannou VE, Spiegelman BM. 1993. A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture. Genes Dev 7:1309–1317. https://doi.org/10.1101/gad.7.7b.1309.
  • Meng Q, Xia Y. 2011. c-Jun, at the crossroad of the signaling network. Protein Cell 2:889–898. https://doi.org/10.1007/s13238-011-1113-3.
  • Nateri AS, Riera-Sans L, Da Costa C, Behrens A. 2004. The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK signaling. Science 303:1374–1378. https://doi.org/10.1126/science.1092880.
  • Vries RG, Prudenziati M, Zwartjes C, Verlaan M, Kalkhoven E, Zantema A. 2001. A specific lysine in c-Jun is required for transcriptional repression by E1A and is acetylated by p300. EMBO J 20:6095–6103. https://doi.org/10.1093/emboj/20.21.6095.
  • Jariel-Encontre I, Salvat C, Steff AM, Pariat M, Acquaviva C, Furstoss O, Piechaczyk M. 1997. Complex mechanisms for c-fos and c-jun degradation. Mol Biol Rep 24:51–56. https://doi.org/10.1023/A:1006804723722.
  • Treier M, Staszewski LM, Bohmann D. 1994. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78:787–798. https://doi.org/10.1016/S0092-8674(94)90502-9.
  • Westermarck J. 2010. Regulation of transcription factor function by targeted protein degradation: an overview focusing on p53, c-Myc, and c-Jun. Methods Mol Biol 647:31–36. https://doi.org/10.1007/978-1-60761-738-9_2.
  • Gao M, Labuda T, Xia Y, Gallagher E, Fang D, Liu YC, Karin M. 2004. Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science 306:271–275. https://doi.org/10.1126/science.1099414.
  • Wertz IE, O'Rourke KM, Zhang Z, Dornan D, Arnott D, Deshaies RJ, Dixit VM. 2004. Human De-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase. Science 303:1371–1374. https://doi.org/10.1126/science.1093549.
  • Xia Y, Wang J, Xu S, Johnson GL, Hunter T, Lu Z. 2007. MEKK1 mediates the ubiquitination and degradation of c-Jun in response to osmotic stress. Mol Cell Biol 27:510–517. https://doi.org/10.1128/MCB.01355-06.
  • Gu Q, Bowden GT, Normolle D, Sun Y. 2007. SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IkappaB-alpha/NF-kappaB. J Cell Biol 178:1009–1023. https://doi.org/10.1083/jcb.200612067.
  • Nakamura T, Hillova J, Mariage-Samson R, Onno M, Huebner K, Cannizzaro LA, Boghosian-Sell L, Croce CM, Hill M. 1992. A novel transcriptional unit of the tre oncogene widely expressed in human cancer cells. Oncogene 7:733–741.
  • Oliveira AM, Hsi BL, Weremowicz S, Rosenberg AE, Dal Cin P, Joseph N, Bridge JA, Perez-Atayde AR, Fletcher JA. 2004. USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst. Cancer Res 64:1920–1923. https://doi.org/10.1158/0008-5472.CAN-03-2827.
  • Erickson-Johnson MR, Chou MM, Evers BR, Roth CW, Seys AR, Jin L, Ye Y, Lau AW, Wang X, Oliveira AM. 2011. Nodular fasciitis: a novel model of transient neoplasia induced by MYH9-USP6 gene fusion. Lab Invest 91:1427–1433. https://doi.org/10.1038/labinvest.2011.118.
  • Oliveira AM, Perez-Atayde AR, Dal Cin P, Gebhardt MC, Chen CJ, Neff JR, Demetri GD, Rosenberg AE, Bridge JA, Fletcher JA. 2005. Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes. Oncogene 24:3419–3426. https://doi.org/10.1038/sj.onc.1208506.
  • Madan B, Walker MP, Young R, Quick L, Orgel KA, Ryan M, Gupta P, Henrich IC, Ferrer M, Marine S, Roberts BS, Arthur WT, Berndt JD, Oliveira AM, Moon RT, Virshup DM, Chou MM, Major MB. 2016. USP6 oncogene promotes Wnt signaling by deubiquitylating Frizzleds. Proc Natl Acad Sci U S A 113:E2945–E2954. https://doi.org/10.1073/pnas.1605691113.
  • Quick L, Young R, Henrich IC, Wang X, Asmann YW, Oliveira AM, Chou MM. 2016. Jak1-STAT3 signals are essential effectors of the USP6/TRE17 oncogene in tumorigenesis. Cancer Res 76:5337–5347. https://doi.org/10.1158/0008-5472.CAN-15-2391.
  • Shao J, Teng Y, Padia R, Hong S, Noh H, Xie X, Mumm JS, Dong Z, Ding HF, Cowell J, Kim J, Han J, Huang S. 2013. COP1 and GSK3beta cooperate to promote c-Jun degradation and inhibit breast cancer cell tumorigenesis. Neoplasia 15:1075–1085. https://doi.org/10.1593/neo.13966.
  • Popov N, Wanzel M, Madiredjo M, Zhang D, Beijersbergen R, Bernards R, Moll R, Elledge SJ, Eilers M. 2007. The ubiquitin-specific protease USP28 is required for MYC stability. Nat Cell Biol 9:765–774. https://doi.org/10.1038/ncb1601.
  • Diefenbacher ME, Popov N, Blake SM, Schulein-Volk C, Nye E, Spencer-Dene B, Jaenicke LA, Eilers M, Behrens A. 2014. The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancer. J Clin Invest 124:3407–3418. https://doi.org/10.1172/JCI73733.
  • Ye Y, Pringle LM, Lau AW, Riquelme DN, Wang H, Jiang T, Lev D, Welman A, Blobel GA, Oliveira AM, Chou MM. 2010. TRE17/USP6 oncogene translocated in aneurysmal bone cyst induces matrix metalloproteinase production via activation of NF-kappaB. Oncogene 29:3619–3629. https://doi.org/10.1038/onc.2010.116.
  • Lachmann A, Xu H, Krishnan J, Berger SI, Mazloom AR, Ma'ayan A. 2010. ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 26:2438–2444. https://doi.org/10.1093/bioinformatics/btq466.
  • Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, Clark NR, Ma'ayan A. 2013. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14:128. https://doi.org/10.1186/1471-2105-14-128.
  • Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, Koplev S, Jenkins SL, Jagodnik KM, Lachmann A, McDermott MG, Monteiro CD, Gundersen GW, Ma'ayan A. 2016. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res 44:W90–W97. https://doi.org/10.1093/nar/gkw377.
  • Li L, Chen W, Liang Y, Ma H, Li W, Zhou Z, Li J, Ding Y, Ren J, Lin J, Han F, Wu J, Han J. 2014. The Gbetagamma-Src signaling pathway regulates TNF-induced necroptosis via control of necrosome translocation. Cell Res 24:417–432. https://doi.org/10.1038/cr.2014.17.
  • Li C, Evans RM. 1997. Ligation independent cloning irrespective of restriction site compatibility. Nucleic Acids Res 25:4165–4166. https://doi.org/10.1093/nar/25.20.4165.
  • Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, Lin SC, Dong MQ, Han J. 2009. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325:332–336. https://doi.org/10.1126/science.1172308.
  • Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X, Perou CM. 2010. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12:R68. https://doi.org/10.1186/bcr2635.
  • Edgar R, Domrachev M, Lash AE. 2002. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30:207–210. https://doi.org/10.1093/nar/30.1.207.
  • Wang X, Bledsoe KL, Graham RP, Asmann YW, Viswanatha DS, Lewis JE, Lewis JT, Chou MM, Yaszemski MJ, Jen J, Westendorf JJ, Oliveira AM. 2014. Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma. Nat Genet 46:666–668. https://doi.org/10.1038/ng.2989.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.